Prospective, multi-center, non-interventional observation to document the success and survival rates of Straumann BLX Implants used for tooth replacement in cleared indications up to 1 year after implant placement
Objective of the study is to confirm the safety and performance of Straumann BLX Implants used for tooth replacement in cleared indications up to 12 months after implant placement. Implants used are Straumann® BLX Implant Roxolid® SLActive®. Regular Base (3.5 mm): implant diameters 3.75 and 4.5mm, in lengths 6, 8, 10, 12,14, 16 and 18 mm Wide Base (4.5 mm): diameter 5.5 mm in lengths 6, 8, 10 and 12 mm
Study Type
OBSERVATIONAL
Enrollment
153
Subjects, male or female at least 18 years old, with the need of dental implant therapy and restoration according to the cleared indications for the implant
Mediplus Praxisklinik
Mainz, Germany
Implant success rate at one year post implant placement
Measured in percent
Time frame: 12 months follow-up period after implantation
Implant survival rate at one year post implant placement
Measured in percent
Time frame: 12 months follow-up period after implantation
Prosthetic success at 12 months post implant placement
Measured in percent
Time frame: 12 months follow-up period after implantation
Prosthetic survival at 12 months post implant placement
Measured in percent
Time frame: 12 months follow-up period after implantation
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.